Hypopituitarism Clinical Trials

8 recruitingLast updated: May 13, 2026

There are 8 actively recruiting hypopituitarism clinical trials across 5 countries. Studies span Early Phase 1, Phase 2, Phase 4. Top locations include Barcelona, Spain, Bethesda, Maryland, United States, Boston, Massachusetts, United States. Updated daily from ClinicalTrials.gov.


Hypopituitarism Trials at a Glance

8 actively recruiting trials for hypopituitarism are listed on ClinicalTrialsFinder across 6 cities in 5 countries. The largest study group is Early Phase 1 with 1 trial, with the heaviest enrollment activity in Barcelona, Bethesda, and Boston. Lead sponsors running hypopituitarism studies include Department of Endocrinology, St Vincents Hospital Sydney, Dr Morton Burt, and Center for Neurological Studies.

Browse hypopituitarism trials by phase

Treatments under study

About Hypopituitarism Clinical Trials

Looking for clinical trials for Hypopituitarism? There are currently 5 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Hypopituitarism trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Hypopituitarism clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting

An Investigation of Pituitary Tumors and Related Hypothalmic Disorders

ProlactinomaCushing DiseasePanhypopituitarism+1 more
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)2,000 enrolled1 locationNCT00001595
Recruiting
Early Phase 1

Identifying Oxytocin Deficiency in Pediatric Patients With Pituitary Disease

HypopituitarismArginine vasopressin deficiencyOxytocin Deficiency+1 more
Massachusetts General Hospital20 enrolled1 locationNCT07568509
Recruiting

Sleep Disorders in Hypothalamic and Pituitary Damage

HypopituitarismSleep Wake DisordersHypothalamic Diseases+1 more
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau60 enrolled1 locationNCT07143266
Recruiting

Pituitary Function After Recovery From Septic Shock Among ICU Survivors

HypopituitarismShock, SepticPituitary Dysfunction
Sanjay Gandhi Postgraduate Institute of Medical Sciences90 enrolled2 locationsNCT05990491
Recruiting

GROWing Up With Rare GENEtic Syndromes

Cornelia De Lange SyndromeCongenital Adrenal HyperplasiaPrader-Willi Syndrome+30 more
dr. Laura C. G. de Graaff-Herder600 enrolled1 locationNCT04463316
Recruiting
Phase 2

Growth Hormone Replacement Therapy for Retried Professional Football Players

HypopituitarismSport injuryConcussion, Brain+3 more
Center for Neurological Studies42 enrolled1 locationNCT04121780
Recruiting

Effect of steroids on blood sugar levels and risk of heart disease in pituitary patients

HypopituitarismSecondary adrenal insufficiency
Dr Morton Burt20 enrolled1 locationACTRN12612000234819
Recruiting
Phase 4

How androgens exert their anabolic effects. Interaction of testosterone and growth hormone at the hepatic level.

Men with hypogonadismMen with hypopituitarism
Department of Endocrinology, St Vincents Hospital Sydney36 enrolled1 locationACTRN12605000482662